Introduction to the Inflammatory Response and Anti-inflammatory Drugs

Core Concepts

The vascular phase: what causes redness, heat, and swelling

Within minutes of injury, chemical mediators cause nearby arterioles to dilate, increasing blood flow — producing redness and heat. At the same time, capillaries become more permeable, so fluid, proteins, and immune cells leak into the tissue; the leaked fluid (exudate) causes swelling (edema), and the swelling plus released chemicals stimulate pain nerves. Mediators such as histamine (from mast cells) and prostaglandins (made by COX enzymes) drive much of this phase.

The cellular phase: white blood cells arrive

Chemicals at the injury site attract leukocytes — chemotaxis. Neutrophils arrive first, then monocytes that mature into macrophages; these cells stick to the vessel wall, squeeze between endothelial cells, and phagocytize (engulf and digest) microbes and debris. Cytokines such as interleukins and tumor necrosis factor coordinate the response and raise the body temperature set point — producing fever, which is protective, not merely a symptom to erase.

The cardinal signs and what they mean

The five classic signs are rubor (redness, from vasodilation), calor (heat, from increased blood flow), tumor (swelling, from fluid and cells leaving the vessels), dolor (pain, from chemical mediators and pressure), and functio laesa (loss of function, from pain and swelling). Each sign maps to a specific mechanism — a useful bedside memory hook.

Acute versus chronic inflammation

Acute inflammation is rapid and short-lived, resolving once the trigger is removed — a sprained ankle or healing cut. Chronic inflammation persists for weeks, months, or years because the trigger persists (autoimmune disease, chronic infection, ongoing irritation) or resolution fails. It is less dramatic but more damaging — underlying rheumatoid arthritis, inflammatory bowel disease, and atherosclerosis — and its therapy is long-term.

NSAIDs: turning down prostaglandins

NSAIDs inhibit cyclooxygenase (COX) enzymes, which convert arachidonic acid into prostaglandins — mediators of pain, fever, and inflammation. Fewer prostaglandins means less vasodilation, less swelling, and quieter pain signaling. Some NSAIDs block both COX-1 and COX-2 (nonselective); others target mainly COX-2 (COX-2 selective). Because prostaglandins also protect the stomach lining and support kidney blood flow, NSAIDs carry well-known risks of stomach irritation, kidney effects, and bleeding (platelets depend on COX-1). These are class-level mechanisms and risks; specific products, doses, and monitoring are verified against current references, the formulary, and prescriber orders.

Acetaminophen: analgesic and antipyretic, not a true anti-inflammatory

Acetaminophen relieves pain and fever through a different (less completely understood) mechanism, has little anti-inflammatory effect, and is not classified as an NSAID. It suits problems where inflammation is not the main issue, but it will not calm a swollen joint the way an NSAID can. Its signature risk is liver injury in overdose, so patients must count all sources of acetaminophen, including combination cold products.

Corticosteroids: the broad switch

Corticosteroids mimic cortisol. Inside cells they alter gene expression, reducing many inflammatory mediators at once — prostaglandins, leukotrienes, cytokines — and suppressing leukocyte activity, making them far more potent than NSAIDs for severe inflammation, allergic reactions, asthma flares, and autoimmune disease. Broad power means broad effects: long-term use can cause adrenal suppression (the body's own cortisol production shuts down), hyperglycemia, weight gain, osteoporosis, and infection risk. Because of adrenal suppression, therapy is tapered, never stopped abruptly — a critical safety principle.

Nursing considerations

• Assess before you treat: check for cardinal signs, ask about fever, and clarify why the drug is ordered — inflammation, pain, or fever — since goals differ.
• Monitor for adverse effects by class: GI upset and bleeding risk with NSAIDs, liver concerns with acetaminophen, and infection risk, blood sugar changes, and adrenal suppression with corticosteroids.
• Teach patients: Don't double up on NSAIDs or acetaminophen-containing products; report dark stools, stomach pain, or signs of infection; never stop corticosteroids abruptly.
• Fever nuance: fever is part of the immune response; treating it is often about comfort and reducing metabolic demand, per clinical judgment and orders.
• Verify all products, doses, and monitoring against current references, the formulary, and prescriber orders; scope and institutional policy vary.

Clinical Scenario: The Sprained Ankle

A classmate twists an ankle during a game; within minutes the joint is red, warm, swollen, and painful. A nursing student narrates the physiology: vasodilation explains the redness and heat, increased capillary permeability explains the swelling, and chemical mediators plus pressure explain the pain — acute, protective, self-limiting inflammation doing its repair work.

Later the classmate asks whether to take ibuprofen (an NSAID) or acetaminophen. The student reasons aloud: the ankle is inflamed, so a drug that reduces prostaglandin-driven swelling and pain — an NSAID-class drug — fits better than acetaminophen, which treats pain and fever but not inflammation. The student also recalls class-level cautions: check for stomach problems or kidney disease before an NSAID, don't combine NSAIDs, and count acetaminophen from all sources. In the clinical setting, the actual product, dose, and monitoring would come from current references and prescriber orders — the reasoning is the study guide; the prescription is the authority.

Common Confusions